0

Organs on Chips Market by Type and Geography - Forecast and Analysis 2022-2026

  • Published: Apr 2022
  • Pages: 120
  • SKU: IRTNTR73098
Technavio

Enjoy complimentary customisation on priority with our Enterprise License!

Safe and Secure SSL Encrypted

info
close
  • Single:

    One user only.
    Quick & easy download option

  • Enterprise:

    Unlimited user access (Within your organization)
    Complimentary Customization Included

2500 USD

The organs on chips market share is expected to increase to USD 73.91 million from 2021 to 2026, and the market's growth momentum will accelerate at a CAGR of 29.34%.

This organs on chips market research report extensively cover organs on chips market segmentations by type (lung, liver, heart, kidney, and others) and geography (North America, Europe, Asia, and Rest of World (ROW)). The organs on chips market report also offers information on several market vendors, including Allevi Inc., Altis Biosystems Inc., AxoSim Inc., BICO Group AB, BiomimX Srl, BIonD Solutions BV, CN Bio Innovations Ltd., Elveflow, Emulate Inc., Hesperos Inc., InSphero AG, Kirkstall Ltd., MIMETAS BV, NETRI, Nortis Inc., SynVivo Inc., TARA Biosystems Inc., and TissUse GmbH among others.

What will the Organs on Chips Market Size be During the Forecast Period?

Organs on Chips Market Size

Download the Free Report Sample to Unlock the Organs on Chips Market Size for the Forecast Period and Other Important Statistics

 

Organs on Chips Market: Key Drivers, Trends, and Challenges

The increasing prevalence of chronic disorders is notably driving the organs on chips market growth, although factors such as high cost of organ-on-chip may impede market growth. Our research analysts have studied the historical data and deduced the key market drivers and the COVID-19 pandemic impact on the organs on chips industry. The holistic analysis of the drivers will help in deducing end goals and refining marketing strategies to gain a competitive edge.

Key Organs on Chips Market Driver

one of the key factors driving the global organs on chips (OOC) growth is the increasing prevalence of chronic disorders. According to the CDC 2020 report, about 795,000 people in the US suffer a stroke each year. Furthermore, an estimated 92.1 million US adults have at least one form of CVD. By 2030, 43.9% of the US adult population is projected to have some form of CVD. Globally, 80% of CVD mortality takes place in low and middle-income countries and occurs almost equally in men and women. In addition, according to the National Institutes of Health (NIH) and the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), more than 661,000 people in the US have kidney failure, 468,000 individuals are on dialysis, and roughly 193,000 live with a functioning kidney transplant. Such factors will drive the growth of the market during the forecast period.

Key Organs on Chips Market Challenge

one of the key challenges to the global OOC market growth is the high cost of organ-on-chip. The overall cost of organs-on-chips includes the cost of the surgical procedure, device and console, and continuing medical surveillance. The total organs-on-chips cost about USD 330 to USD 2700 a year to maintain. Furthermore, most of these devices are not covered by insurance. Due to the high cost, the adoption rate of organ-on-chip is significantly lower in developing economies. Additionally, end-users from a few developing countries such as India, Brazil, and Iran have low awareness of technologically advanced organs-on-chips and low purchasing power. Such factors will hamper the potential growth of the global organs-on-chips market during the forecast period.

Key Organs on Chips Market Trend

Growing number of partnerships and collaborations between pharmaceutical companies and organs-on-chips manufacturers is one of the key organs on chips market trends that is expected to impact the industry positively in the forecast period. For instance, in 2020, CN Bio and Imperial College London collaborated to harness CN Bio's liver-on-chip technology to advance the understanding of the underlying mechanisms of alcoholic hepatitis and uncover novel targets for drug discovery and development. In October 2020, the United States Food and Drug Administration entered a collaborative agreement to use lung chips from Emulate Inc. to evaluate the safety of COVID-19 vaccines and protective immunity against SARS-CoV-2. In October 2020, researchers at the US Army Combat Capabilities Development Command (CCDC) and Chemical Biological Center (CBC) used Emulat's lung-on-chip technology for research on COVID-19.  Such factors are expected to further support the growth of the market during the forecast years.

This organs on chips market analysis report also provides detailed information on other upcoming trends and challenges that will have a far-reaching effect on the market growth. The actionable insights on the trends and challenges will help companies evaluate and develop growth strategies for 2022-2026.

Who are the Major Organs on Chips Market Vendors?

The report analyzes the market's competitive landscape and offers information on several market vendors, including:

 

  • Allevi Inc.
  • Altis Biosystems Inc.
  • AxoSim Inc.
  • BICO Group AB
  • BiomimX Srl
  • BIonD Solutions BV
  • CN Bio Innovations Ltd.
  • Elveflow
  • Emulate Inc.
  • Hesperos Inc.
  • InSphero AG
  • Kirkstall Ltd.
  • MIMETAS BV
  • NETRI
  • Nortis Inc.
  • SynVivo Inc.
  • TARA Biosystems Inc.
  • TissUse GmbH

 

This statistical study of the organs on chips market encompasses successful business strategies deployed by the key vendors. The organs on chips market is fragmented and the vendors are deploying growth strategies such as investment in R&D to compete in the market.

Product Insights and News

  • AxoSim Inc. - The company offers organs on chips products such as NerveSim and BrainSim. 
  • AxoSim Inc. - Under the unified segment, the company offers a neuroscience discovery platform used to develop a 3D cell-based platform. 

To make the most of the opportunities and recover from post COVID-19 impact, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.

The organs on chips market forecast report offers in-depth insights into key vendor profiles. The profiles include information on the production, sustainability, and prospects of the leading companies.

Which are the Key Regions for Organs on Chips Market?

Organs on Chips Market Market segmentation by region

For more insights on the market share of various regions Request for a FREE sample now!

35% of the market's growth will originate from North America during the forecast period. US and Canada are the key markets for organs on chips in North America. Market growth in this region will be faster than the growth of the market in Rest of World (ROW).

The availability of a wide range of services offered by major players and an increase in toxicological testing of chemicals on the different types of organ cells will facilitate the organ on chips market growth in North America over the forecast period. This market research report entails detailed information on the competitive intelligence, marketing gaps, and regional opportunities in store for vendors, which will assist in creating efficient business plans.

COVID Impact and Recovery Analysis

 In 2020, the outbreak of COVID-19 severely impacted the organ-on-chip market in North America. The exponential rise in the number of COVID-19 cases compelled the governments of various countries in the region to impose restrictions on businesses and transportation activities, which led to the closure of manufacturing units and affected the distribution of organs on chips. However, in 2021, the introduction of COVID-19 vaccines resulted in the lifting of lockdowns and the rescheduling of surgical operations in the region. Such factors are expected to drive the growth of the regional market during the forecast period.

What are the Revenue-generating Type Segments in the Organs on Chips Market?

Organs on Chips Market Segmentation

To gain further insights on the market contribution of various segments Request for a FREE sample

The organ on chips market share growth by the lung segment will be significant during the forecast period. The growing awareness and demand for lungs on chips are expected to positively impact the growth of the global organs-on-chips market in the coming years.

This report provides an accurate prediction of the contribution of all the segments to the growth of the organs on chips market size and actionable market insights on post COVID-19 impact on each segment.

Organs on Chips Market Value Chain Analysis

Our report provides extensive information on the value chain analysis for the organs on chips market, which vendors can leverage to gain a competitive advantage during the forecast period. The end-to-end understanding of the value chain is essential in profit margin optimization and evaluation of business strategies. The data available in our value chain analysis segment can help vendors drive costs and enhance customer services during the forecast period.

Parent Market Analysis

Technavio categorizes the global organs-on-chips market as a part of the global life science tools and services market. Our research report has extensively covered external factors influencing the parent market growth potential in the coming years, which will determine the levels of growth of the organs on chips market during the forecast period.

 

Organs on Chips Market Scope

Report Coverage

Details

Page number

120

Base year

2021

Forecast period

2022-2026

Growth momentum & CAGR

Accelerate at a CAGR of 29.34%

Market growth 2022-2026

$ 73.91 million

Market structure

Fragmented

YoY growth (%)

28.24

Regional analysis

North America, Europe, Asia, and Rest of World (ROW)

Performing market contribution

North America at 35%

Key consumer countries

US, Canada, Germany, France, and Japan

Competitive landscape

Leading companies, Competitive strategies, Consumer engagement scope

Key companies profiled

Allevi Inc., Altis Biosystems Inc., AxoSim Inc., BICO Group AB, BiomimX Srl, BIonD Solutions BV, CN Bio Innovations Ltd., Elveflow, Emulate Inc., Hesperos Inc., InSphero AG, Kirkstall Ltd., MIMETAS BV, NETRI, Nortis Inc., SynVivo Inc., TARA Biosystems Inc., and TissUse GmbH

Market dynamics

Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and recovery analysis and future consumer dynamics, Market condition analysis for forecast period

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Request for a FREE sample

What are the Key Data Covered in this Organs on Chips Market Report?

  • CAGR of the market during the forecast period 2022-2026
  • Detailed information on factors that will drive organs on chips market growth during the next five years
  • Precise estimation of the organs on chips market size and its contribution to the parent market
  • Accurate predictions on upcoming trends and changes in consumer behavior
  • The growth of the organs on chips industry across North America, Europe, Asia, and Rest of World (ROW)
  • A thorough analysis of the market's competitive landscape and detailed information on vendors
  • Comprehensive details of factors that will challenge the growth of organs on chips market vendors

We can help! Our analysts can customize this report to meet your requirements. Get in touch

1 Executive Summary

  • 1.1 Market overview
    • Exhibit 01: Executive Summary – Chart on Market Overview
    • Exhibit 02: Executive Summary – Data Table on Market Overview
    • Exhibit 03: Executive Summary – Chart on Global Market Characteristics
    • Exhibit 04: Executive Summary – Chart on Market by Geography
    • Exhibit 05: Executive Summary – Chart on Market Segmentation by Type
    • Exhibit 06: Executive Summary – Chart on Incremental Growth
    • Exhibit 07: Executive Summary – Data Table on Incremental Growth
    • Exhibit 08: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
    • Exhibit 09: Parent market
    • Exhibit 10: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
    • Exhibit 11: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
    • Exhibit 12: Market segments
  • 3.3 Market size 2021
    • 3.4 Market outlook: Forecast for 2021-2026
      • Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
      • Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
      • Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
      • Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)

    4 Five Forces Analysis

    • 4.1 Five forces summary
      • Exhibit 17: Five forces analysis - Comparison between2021 and 2026
    • 4.2 Bargaining power of buyers
      • Exhibit 18: Chart on Bargaining power of buyers – Impact of key factors 2021 and 2026
    • 4.3 Bargaining power of suppliers
      • Exhibit 19: Bargaining power of suppliers – Impact of key factors in 2021 and 2026
    • 4.4 Threat of new entrants
      • Exhibit 20: Threat of new entrants – Impact of key factors in 2021 and 2026
    • 4.5 Threat of substitutes
      • Exhibit 21: Threat of substitutes – Impact of key factors in 2021 and 2026
    • 4.6 Threat of rivalry
      • Exhibit 22: Threat of rivalry – Impact of key factors in 2021 and 2026
    • 4.7 Market condition
      • Exhibit 23: Chart on Market condition - Five forces 2021 and 2026

    5 Market Segmentation by Type

    • 5.1 Market segments
      • Exhibit 24: Chart on Type - Market share 2021-2026 (%)
      • Exhibit 25: Data Table on Type - Market share 2021-2026 (%)
    • 5.2 Comparison by Type
      • Exhibit 26: Chart on Comparison by Type
      • Exhibit 27: Data Table on Comparison by Type
    • 5.3 Lung - Market size and forecast 2021-2026
      • Exhibit 28: Chart on Lung - Market size and forecast 2021-2026 ($ million)
      • Exhibit 29: Data Table on Lung - Market size and forecast 2021-2026 ($ million)
      • Exhibit 30: Chart on Lung - Year-over-year growth 2021-2026 (%)
      • Exhibit 31: Data Table on Lung - Year-over-year growth 2021-2026 (%)
    • 5.4 Liver - Market size and forecast 2021-2026
      • Exhibit 32: Chart on Liver - Market size and forecast 2021-2026 ($ million)
      • Exhibit 33: Data Table on Liver - Market size and forecast 2021-2026 ($ million)
      • Exhibit 34: Chart on Liver - Year-over-year growth 2021-2026 (%)
      • Exhibit 35: Data Table on Liver - Year-over-year growth 2021-2026 (%)
    • 5.5 Heart - Market size and forecast 2021-2026
      • Exhibit 36: Chart on Heart - Market size and forecast 2021-2026 ($ million)
      • Exhibit 37: Data Table on Heart - Market size and forecast 2021-2026 ($ million)
      • Exhibit 38: Chart on Heart - Year-over-year growth 2021-2026 (%)
      • Exhibit 39: Data Table on Heart - Year-over-year growth 2021-2026 (%)
    • 5.6 Kidney - Market size and forecast 2021-2026
      • Exhibit 40: Chart on Kidney - Market size and forecast 2021-2026 ($ million)
      • Exhibit 41: Data Table on Kidney - Market size and forecast 2021-2026 ($ million)
      • Exhibit 42: Chart on Kidney - Year-over-year growth 2021-2026 (%)
      • Exhibit 43: Data Table on Kidney - Year-over-year growth 2021-2026 (%)
    • 5.7 Others - Market size and forecast 2021-2026
      • Exhibit 44: Chart on Others - Market size and forecast 2021-2026 ($ million)
      • Exhibit 45: Data Table on Others - Market size and forecast 2021-2026 ($ million)
      • Exhibit 46: Chart on Others - Year-over-year growth 2021-2026 (%)
      • Exhibit 47: Data Table on Others - Year-over-year growth 2021-2026 (%)
    • 5.8 Market opportunity by Type
      • Exhibit 48: Market opportunity by Type ($ million)

    6 Customer Landscape

    • 6.1 Customer landscape overview
      • Exhibit 49: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

    7 Geographic Landscape

    • 7.1 Geographic segmentation
      • Exhibit 50: Chart on Market share by geography 2021-2026 (%)
      • Exhibit 51: Data Table on Market share by geography 2021-2026 (%)
    • 7.2 Geographic comparison
      • Exhibit 52: Chart on Geographic comparison
      • Exhibit 53: Data Table on Geographic comparison
    • 7.3 North America - Market size and forecast 2021-2026
      • Exhibit 54: Chart on North America - Market size and forecast 2021-2026 ($ million)
      • Exhibit 55: Data Table on North America - Market size and forecast 2021-2026 ($ million)
      • Exhibit 56: Chart on North America - Year-over-year growth 2021-2026 (%)
      • Exhibit 57: Data Table on North America - Year-over-year growth 2021-2026 (%)
    • 7.4 Europe - Market size and forecast 2021-2026
      • Exhibit 58: Chart on Europe - Market size and forecast 2021-2026 ($ million)
      • Exhibit 59: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
      • Exhibit 60: Chart on Europe - Year-over-year growth 2021-2026 (%)
      • Exhibit 61: Data Table on Europe - Year-over-year growth 2021-2026 (%)
    • 7.5 Asia - Market size and forecast 2021-2026
      • Exhibit 62: Chart on Asia - Market size and forecast 2021-2026 ($ million)
      • Exhibit 63: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
      • Exhibit 64: Chart on Asia - Year-over-year growth 2021-2026 (%)
      • Exhibit 65: Data Table on Asia - Year-over-year growth 2021-2026 (%)
    • 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
      • Exhibit 66: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
      • Exhibit 67: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
      • Exhibit 68: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
      • Exhibit 69: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
    • 7.7 US - Market size and forecast 2021-2026
      • Exhibit 70: Chart on US - Market size and forecast 2021-2026 ($ million)
      • Exhibit 71: Data Table on US - Market size and forecast 2021-2026 ($ million)
      • Exhibit 72: Chart on US - Year-over-year growth 2021-2026 (%)
      • Exhibit 73: Data Table on US - Year-over-year growth 2021-2026 (%)
    • 7.8 Germany - Market size and forecast 2021-2026
      • Exhibit 74: Chart on Germany - Market size and forecast 2021-2026 ($ million)
      • Exhibit 75: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
      • Exhibit 76: Chart on Germany - Year-over-year growth 2021-2026 (%)
      • Exhibit 77: Data Table on Germany - Year-over-year growth 2021-2026 (%)
    • 7.9 France - Market size and forecast 2021-2026
      • Exhibit 78: Chart on France - Market size and forecast 2021-2026 ($ million)
      • Exhibit 79: Data Table on France - Market size and forecast 2021-2026 ($ million)
      • Exhibit 80: Chart on France - Year-over-year growth 2021-2026 (%)
      • Exhibit 81: Data Table on France - Year-over-year growth 2021-2026 (%)
    • 7.10 Canada - Market size and forecast 2021-2026
      • Exhibit 82: Chart on Canada - Market size and forecast 2021-2026 ($ million)
      • Exhibit 83: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
      • Exhibit 84: Chart on Canada - Year-over-year growth 2021-2026 (%)
      • Exhibit 85: Data Table on Canada - Year-over-year growth 2021-2026 (%)
    • 7.11 Japan - Market size and forecast 2021-2026
      • Exhibit 86: Chart on Japan - Market size and forecast 2021-2026 ($ million)
      • Exhibit 87: Data Table on Japan - Market size and forecast 2021-2026 ($ million)
      • Exhibit 88: Chart on Japan - Year-over-year growth 2021-2026 (%)
      • Exhibit 89: Data Table on Japan - Year-over-year growth 2021-2026 (%)
    • 7.12 Market opportunity by geography
      • Exhibit 90: Market opportunity by geography ($ million)

    8 Drivers, Challenges, and Trends

    • 8.1 Market drivers
      • 8.2 Market challenges
        • 8.3 Impact of drivers and challenges
          • Exhibit 91: Impact of drivers and challenges in 2021 and 2026
        • 8.4 Market trends

          9 Vendor Landscape

          • 9.1 Overview
            • 9.2 Vendor landscape
              • Exhibit 92: Overview on Criticality of inputs and Factors of differentiation
            • 9.3 Landscape disruption
              • Exhibit 93: Overview on factors of disruption
            • 9.4 Industry risks
              • Exhibit 94: Impact of key risks on business

            10 Vendor Analysis

            • 10.1 Vendors covered
              • Exhibit 95: Vendors covered
            • 10.2 Market positioning of vendors
              • Exhibit 96: Matrix on vendor position and classification
            • 10.3 AxoSim Inc.
              • Exhibit 97: AxoSim Inc. - Overview
              • Exhibit 98: AxoSim Inc. - Product / Service
              • Exhibit 99: AxoSim Inc. - Key offerings
            • 10.4 BiomimX Srl
              • Exhibit 100: BiomimX Srl - Overview
              • Exhibit 101: BiomimX Srl - Product / Service
              • Exhibit 102: BiomimX Srl - Key offerings
            • 10.5 Elveflow
              • Exhibit 103: Elveflow - Overview
              • Exhibit 104: Elveflow - Product / Service
              • Exhibit 105: Elveflow - Key offerings
            • 10.6 Emulate Inc.
              • Exhibit 106: Emulate Inc. - Overview
              • Exhibit 107: Emulate Inc. - Product / Service
              • Exhibit 108: Emulate Inc. - Key offerings
            • 10.7 InSphero AG
              • Exhibit 109: InSphero AG - Overview
              • Exhibit 110: InSphero AG - Product / Service
              • Exhibit 111: InSphero AG - Key news
              • Exhibit 112: InSphero AG - Key offerings
            • 10.8 Kirkstall Ltd.
              • Exhibit 113: Kirkstall Ltd. - Overview
              • Exhibit 114: Kirkstall Ltd. - Product / Service
              • Exhibit 115: Kirkstall Ltd. - Key offerings
            • 10.9 MIMETAS BV
              • Exhibit 116: MIMETAS BV - Overview
              • Exhibit 117: MIMETAS BV - Product / Service
              • Exhibit 118: MIMETAS BV - Key offerings
            • 10.10 Nortis Inc.
              • Exhibit 119: Nortis Inc. - Overview
              • Exhibit 120: Nortis Inc. - Product / Service
              • Exhibit 121: Nortis Inc. - Key offerings
            • 10.11 SynVivo Inc.
              • Exhibit 122: SynVivo Inc. - Overview
              • Exhibit 123: SynVivo Inc. - Product / Service
              • Exhibit 124: SynVivo Inc. - Key offerings
            • 10.12 TissUse GmbH
              • Exhibit 125: TissUse GmbH - Overview
              • Exhibit 126: TissUse GmbH - Product / Service
              • Exhibit 127: TissUse GmbH - Key offerings

            11 Appendix

            • 11.1 Scope of the report
              • 11.2 Inclusions and exclusions checklist
                • Exhibit 128: Inclusions checklist
                • Exhibit 129: Exclusions checklist
              • 11.3 Currency conversion rates for US$
                • Exhibit 130: Currency conversion rates for US$
              • 11.4 Research methodology
                • Exhibit 131: Research methodology
                • Exhibit 132: Validation techniques employed for market sizing
                • Exhibit 133: Information sources
              • 11.5 List of abbreviations
                • Exhibit 134: List of abbreviations

              Research Framework

              Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

              TechnavioINFORMATION SOURCES

              Primary sources

              • Manufacturers and suppliers
              • Channel partners
              • Industry experts
              • Strategic decision makers

              Secondary sources

              • Industry journals and periodicals
              • Government data
              • Financial reports of key industry players
              • Historical data
              • Press releases
              Technavio

              TechnavioDATA ANALYSIS

              Data Synthesis

              • Collation of data
              • Estimation of key figures
              • Analysis of derived insights

              Data Validation

              • Triangulation with data models
              • Reference against proprietary databases
              • Corroboration with industry experts
              Technavio

              TechnavioREPORT WRITING

              Qualitative

              • Market drivers
              • Market challenges
              • Market trends
              • Five forces analysis

              Quantitative

              • Market size and forecast
              • Market segmentation
              • Geographical insights
              • Competitive landscape
              Interested in this report?
              Get your sample now!
              Organs on Chips market growth will increase by $73.91 million during 2022-2026.
              The organs on chips market is expected to grow at a CAGR of 29.34% during 2022-2026.
              Technavio has segmented the organs on chips market by type (Lung, Liver, Heart, and Kidney) and geographic (North America, Europe, Asia, and Rest of World (ROW)).
              Allevi Inc., Altis Biosystems Inc., AxoSim Inc., BICO Group AB, BiomimX Srl, BIOND Solutions BV, CN Bio Innovations Ltd., Elveflow, Emulate Inc., Hesperos Inc., InSphero AG, Kirkstall Ltd., MIMETAS BV, NETRI, Nortis Inc., SynVivo?áInc., TARA Biosystems Inc., TissUse GmbH are a few of the key vendors in the organs on chips market.
              North America will register the highest growth rate of 34.93% among the other regions. Therefore, the organs on chips market in North America is expected to garner significant business opportunities for the vendors during the forecast period.
              • US
              • Canada
              • Germany
              • France
              • Japan
              The key factors driving the organs on chips market growth are:
              • Increasing prevalence of chronic disorders
              • Growing number of partnerships and collaborations between pharmaceutical companies and organs-on-chips manufacturers
              The organs on chips market vendors should focus on grabbing business opportunities from the lung segment as it accounted for the largest market share in the base year.
              • What are the key global market and the regional market share?
              • What are the revenue-generating key market segments?
              • What are the key factors driving and challenging this market’s growth?
              • Who are the key market vendors and their growth strategies?
              • What are the latest trends influencing the growth of this market?
              • What are the variables influencing the market growth in the primary regions?
              • What are the factors influencing the growth of the parent market?
              • Off-the-shelf research reports
              • Reports can be tailored to meet the customer's needs
              • Trusted by more than 100 fortune 500 organizations
              • Information about the market's key drivers, trends, and challenges
              • Parent market analysis
              • Every week, 50,000 people visit our subscription platform
              • Detailed vendors report with competitive landscape
              • Covid-19 impact and recovery analysis
              • Data on revenue-generating market segments
              • Details on the market shares of various regions
              • Five-force market analysis

              Certified ISO 9001 : 2015

              We are ISO recognized

              We are ISO 9001:2015 recognized that ensures quality services and product delivery to our clients.

              We are GDPR and CCPA compliant

              We are GDPR and CCPA compliant! Your transaction & personal information is protected from unauthorized use.

              Safe and Secure SSL Encrypted
              Technavio

              info
              close
              • Single:

                One user only.
                Quick & easy download option

              • Enterprise:

                Unlimited user access (Within your organization)
                Complimentary Customization Included

              2500 USD

              Technavio Get the report (PDF) sent to your email within minutes.

              Subscribe & Save

              Get lifetime access to our
              Technavio Insights

              Customized Report as per your Business Needs

              • Our analysts will work directly with you and understand your needs
              • Get data on specified regions or segments, competitor and Vendors
              • Data will be formatted and presented as per your requirements
              • We offer $1000 worth of FREE customization at the time of purchase

              Let us help you make report more suited to your requirements.

              • Get a competitive breakdown as per your niche industry
              • Customize the data with various metrics that meet your business prerequisite
              • Understand Revenue Sources, Customers and many more
              • Details on Market Share
              • These customizations are done in a short amount of time by our analysts and industry experts
              Technavio
              Enquire Before Buying
              17,000 reports available | Plans starting from just 5,000 USD | Get FREE trial>>